U 92798
Latest Information Update: 22 Jan 1997
At a glance
- Originator Pharmacia Corporation
 - Class Anti-ischaemics
 - Mechanism of Action Calcium channel antagonists; Lipid peroxidation inhibitors
 
- 
          
            
              Orphan Drug Status
              No
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
 
Highest Development Phases
- No development reported Cognition disorders
 
Most Recent Events
- 22 Jan 1997 No-Development-Reported for Cognition disorders in USA (Unknown route)
 - 07 Dec 1994 Preclinical development for Cognition disorders in USA (Unknown route)